2021-12-092021-12-092009-08Şentürk, T. vd. (2009). "Capecitabine-induced cardiotoxicity mimicking myocardial infarction". Netherlands Heart Journal, 17(7-8), 277-280.1568-5888https://doi.org/10.1007/BF03086265https://link.springer.com/article/10.1007%2FBF03086265http://hdl.handle.net/11452/23117Capecitabine, a fluoropyrimidine derivative, is an orally administered drug that delivers 5-fluorouracil (5-FU) selectively to the tumour. The drug has demonstrated activity in metastatic colorectal cancer. We describe a male patient receiving capecitabine therapy with typical chest pain and electrocardiographic changes consistent with ST-segment elevation myocardial infarction. Capecitabine-induced cardiotoxicity may develop in patients who have had a previous episode of 5-FU-induced cardiotoxicity. Capecitabine-induced cardiotoxicity is a rare condition that may lead to diagnostic and therapeutic dilemmas.eninfo:eu-repo/semantics/openAccessCapecitabineCardiotoxicityMyocardial infarctionCardiovascular system & cardiologyArticle0002691789000042-s2.0-70349283313277280177-819789694Cardiac & cardiovascular systemsCapecitabine; Cardiotoxicity; Coronary Artery SpasmCapecitabineDiltiazemFluorouracilFolinic acidIsosorbide mononitrateOxaliplatinAdultArticleCancer adjuvant therapyCardiotoxicityCase reportClinical featureContinuous infusionDifferential diagnosisDrug effectHeart infarctionHumanMaleRectum carcinomaST segment elevationSymptomThorax pain